Search - tctmd.com

Displaying 1 - 20 of 216

Sort: Relevancy | Date

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Daily News

CMS Greenlights Reimbursement for Renal Denervation Systems

L.A. McKeown

October 29, 2025

News Daily News

CMS Issues Proposed Coverage Decision for Renal Denervation

Todd Neale

July 11, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Daily News

CMS Opens Coverage Analysis for Renal Denervation

Todd Neale

January 14, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2024

Caitlin E. Cox

December 31, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Presentation TCT 2024

Science of Ultrasound RDN

Presenter: Michael Joner

October 28, 2024

Presentation TCT 2024

Getting Started: Establishing a Patient Care Pathway

Presenter: Matheen Khuddus

October 28, 2024

Presentation TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

Presenter: Roland Schmieder

October 28, 2024

Presentation TCT 2024

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

Presenter: Manasa Jasti

October 28, 2024

Presentation TCT 2024

TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

Presenter: Abraham Tzafriri

October 28, 2024

Advertisement

What’s Going to Be Hot at AHA 2025?

CMS Greenlights Reimbursement for Renal Denervation Systems

CMS Issues Proposed Coverage Decision for Renal Denervation

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

CMS Opens Coverage Analysis for Renal Denervation

TCTMD’s Top 10 Most Popular Stories for December 2024

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

What Evaluation is Required for Patient Selection for RDN?

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What’s Next - Going into 2025

Science of Ultrasound RDN

Getting Started: Establishing a Patient Care Pathway

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

TCT 486: Ultrasound Based Renal Denervation Reduces Blood Pressure in Patients With Chronic Kidney Disease: Results of a Multicenter Prospective Randomized Sham-Controlled Blinded Investigator Initiated Trial

TCT 485: Device-Related Adverse Events and Modes of Failure Related to Renal Denervation Systems: Insights From Analysis of the FDA MAUDE Database

TCT 484: Twelve Week Safety and Efficacy of a Novel Extravascular Bi-lateral Renal Denervation Device in a Porcine Model at Nominal Dose

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content